Is Cerevel Therapeutics Holdings, Inc. (CERE) a Buy, Sell, or Hold?
NASDAQ : CERE
Cerevel Therapeutics Holdings, Inc.
$44.96 USD
$0.33 (0.74%)
- Volume
- 15.03M
- Average Volume
- 2.11M
- Market Capitalization
- $8.19B
- P/E Ratio
- -16.84
- Dividend Yield
- 0.00%
- Price Target
- $33.50
- Year High
- $44.99
- Year Low
- $19.59
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.92
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
53
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
58
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$1.65M
CERE Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
CERE Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| PFIZER INC | other: Former 10% Owner | 2024-08-01 | U-Tender | 45 | 2024-08-05 |
| BAIN CAPITAL INVESTORS LLC | director, 10 percent owner: | 2024-08-01 | D-Return | 45 | 2024-08-05 |
| Gordon Christopher R | director, 10 percent owner: | 2024-08-01 | D-Return | 45 | 2024-08-05 |
| Gordon Christopher R | director, 10 percent owner: | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Gordon Christopher R | director, 10 percent owner: | 2024-08-01 | D-Return | 45 | 2024-08-05 |
| Gordon Christopher R | director, 10 percent owner: | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Koppel Adam | director, 10 percent owner: | 2024-08-01 | D-Return | 45 | 2024-08-05 |
| Koppel Adam | director, 10 percent owner: | 2024-08-01 | D-Return | 45 | 2024-08-05 |
| Koppel Adam | director, 10 percent owner: | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Koppel Adam | director, 10 percent owner: | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Sanchez Ramiro | officer: Chief Medical Officer | 2024-08-01 | D-Return | 45 | 2024-08-05 |
| Sanchez Ramiro | officer: Chief Medical Officer | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Sanchez Ramiro | officer: Chief Medical Officer | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Giordano Douglas E. | director | 2024-08-01 | D-Return | 45 | 2024-08-05 |
| Giordano Douglas E. | director | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Giordano Douglas E. | director | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Renaud Ronald C JR | director, officer: President & CEO | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Renaud Ronald C JR | director, officer: President & CEO | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Renaud Ronald C JR | director, officer: President & CEO | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Renaud Ronald C JR | director, officer: President & CEO | 2024-08-01 | D-Return | 45 | 2024-08-05 |
| Mckernan Ruth | director | 2024-08-01 | D-Return | 45 | 2024-08-05 |
| Mckernan Ruth | director | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Mckernan Ruth | director | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Akamine Scott | officer: Chief Legal Officer | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Akamine Scott | officer: Chief Legal Officer | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Akamine Scott | officer: Chief Legal Officer | 2024-08-01 | D-Return | 45 | 2024-08-05 |
| Sulzberger Gabrielle | director | 2024-08-01 | D-Return | 45 | 2024-08-05 |
| Sulzberger Gabrielle | director | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Sulzberger Gabrielle | director | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Renger John | officer: Chief Scientific Officer | 2024-08-01 | D-Return | 45 | 2024-08-05 |
| Renger John | officer: Chief Scientific Officer | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Renger John | officer: Chief Scientific Officer | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| DiPietro Kenneth | officer: Chief Human Resources Officer | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| DiPietro Kenneth | officer: Chief Human Resources Officer | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| DiPietro Kenneth | officer: Chief Human Resources Officer | 2024-08-01 | D-Return | 45 | 2024-08-05 |
| Tregoning Kathleen | officer: See Remarks | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Tregoning Kathleen | officer: See Remarks | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Tregoning Kathleen | officer: See Remarks | 2024-08-01 | D-Return | 45 | 2024-08-05 |
| DEKKERS MARIJN E | director | 2024-08-01 | D-Return | 45 | 2024-08-05 |
| DEKKERS MARIJN E | director | 2024-08-01 | D-Return | 45 | 2024-08-05 |
| DEKKERS MARIJN E | director | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| DEKKERS MARIJN E | director | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| ALTSCHULLER Susan | officer: Chief Financial Officer | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| ALTSCHULLER Susan | officer: Chief Financial Officer | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| ALTSCHULLER Susan | officer: Chief Financial Officer | 2024-08-01 | D-Return | 45 | 2024-08-05 |
| RIEDEL NORBERT G | director | 2024-08-01 | D-Return | 45 | 2024-08-05 |
| RIEDEL NORBERT G | director | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| RIEDEL NORBERT G | director | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Bodenrader Mark | officer: See Remarks | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Bodenrader Mark | officer: See Remarks | 2024-08-01 | D-Return | 45 | 2024-08-05 |
| Bodenrader Mark | officer: See Remarks | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| PATRICK DEVAL L | director | 2024-08-01 | D-Return | 45 | 2024-08-05 |
| PATRICK DEVAL L | director | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| PATRICK DEVAL L | director | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| COLES N ANTHONY | director | 2024-08-01 | D-Return | 45 | 2024-08-05 |
| COLES N ANTHONY | director | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| COLES N ANTHONY | director | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| COLES N ANTHONY | director | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Burgess Paul D. | officer: See Remarks | 2024-08-01 | D-Return | 45 | 2024-08-05 |
| Burgess Paul D. | officer: See Remarks | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| Burgess Paul D. | officer: See Remarks | 2024-08-01 | D-Return | 0 | 2024-08-05 |
| COLES N ANTHONY | director | 2024-07-01 | M-Exempt | 3.5 | 2024-07-03 |
| COLES N ANTHONY | director | 2024-07-01 | M-Exempt | 3.5 | 2024-07-03 |
| COLES N ANTHONY | director | 2024-07-01 | S-Sale | 41.1814 | 2024-07-03 |
| Gordon Christopher R | director, 10 percent owner: | 2024-06-05 | A-Award | 0 | 2024-06-07 |
| Koppel Adam | director, 10 percent owner: | 2024-06-05 | A-Award | 0 | 2024-06-07 |
| COLES N ANTHONY | director | 2024-06-05 | A-Award | 0 | 2024-06-07 |
| DEKKERS MARIJN E | director | 2024-06-05 | A-Award | 0 | 2024-06-07 |
| PATRICK DEVAL L | director | 2024-06-05 | A-Award | 0 | 2024-06-07 |
| RIEDEL NORBERT G | director | 2024-06-05 | A-Award | 0 | 2024-06-07 |
| Giordano Douglas E. | director | 2024-06-05 | A-Award | 0 | 2024-06-07 |
| Sulzberger Gabrielle | director | 2024-06-05 | A-Award | 0 | 2024-06-07 |
| Mckernan Ruth | director | 2024-06-05 | A-Award | 0 | 2024-06-07 |
| COLES N ANTHONY | director | 2024-06-03 | M-Exempt | 3.5 | 2024-06-05 |
| COLES N ANTHONY | director | 2024-06-03 | M-Exempt | 3.5 | 2024-06-05 |
| COLES N ANTHONY | director | 2024-06-03 | S-Sale | 40.6104 | 2024-06-05 |
| COLES N ANTHONY | director | 2024-05-10 | M-Exempt | 3.5 | 2024-05-14 |
| COLES N ANTHONY | director | 2024-05-10 | M-Exempt | 3.5 | 2024-05-14 |
| COLES N ANTHONY | director | 2024-05-10 | S-Sale | 42.1025 | 2024-05-14 |
| COLES N ANTHONY | director | 2024-04-01 | M-Exempt | 3.5 | 2024-04-03 |
| COLES N ANTHONY | director | 2024-04-01 | M-Exempt | 3.5 | 2024-04-03 |
| COLES N ANTHONY | director | 2024-04-01 | S-Sale | 42.3328 | 2024-04-03 |
| COLES N ANTHONY | director | 2024-03-04 | M-Exempt | 3.5 | 2024-03-06 |
| COLES N ANTHONY | director | 2024-03-04 | M-Exempt | 3.5 | 2024-03-06 |
| COLES N ANTHONY | director | 2024-03-04 | S-Sale | 41.011 | 2024-03-06 |
| COLES N ANTHONY | director | 2024-02-29 | M-Exempt | 3.5 | 2024-03-04 |
| COLES N ANTHONY | director | 2024-02-29 | M-Exempt | 3.5 | 2024-03-04 |
| COLES N ANTHONY | director | 2024-02-29 | S-Sale | 41.1578 | 2024-03-04 |
| PERCEPTIVE ADVISORS LLC | director | 2024-02-20 | G-Gift | 0 | 2024-02-21 |
| Sulzberger Gabrielle | 2023-12-31 | 0 | 2024-02-13 | ||
| Renger John | officer: Chief Scientific Officer | 2024-02-06 | M-Exempt | 0 | 2024-02-08 |
| Renger John | officer: Chief Scientific Officer | 2024-02-06 | M-Exempt | 0 | 2024-02-08 |
| Renger John | officer: Chief Scientific Officer | 2024-02-07 | S-Sale | 41.5441 | 2024-02-08 |
| COLES N ANTHONY | director | 2024-02-06 | M-Exempt | 0 | 2024-02-08 |
| COLES N ANTHONY | director | 2024-02-06 | M-Exempt | 0 | 2024-02-08 |
| COLES N ANTHONY | director | 2024-02-07 | S-Sale | 41.5441 | 2024-02-08 |
| ALTSCHULLER Susan | officer: Chief Financial Officer | 2024-01-19 | A-Award | 0 | 2024-01-23 |
| Renger John | officer: Chief Scientific Officer | 2024-01-19 | A-Award | 0 | 2024-01-23 |
| Tregoning Kathleen | officer: See Remarks | 2024-01-19 | A-Award | 0 | 2024-01-23 |
| DiPietro Kenneth | officer: Chief Human Resources Officer | 2024-01-19 | A-Award | 0 | 2024-01-23 |